Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Joji Kuramoto"'
Autor:
Maiko Sasaki-Toda, Yumiko Ogawa-Kobayashi, Yoshiki Kuwabara, Kazutsugu Uematsu, Yusuke Hirata, Shintaro Mikami, Joji Kuramoto, Kosuke Sakai, Hiroaki Nishimura, Hiroyuki Kyoyama, Akihiko Gemma, Yuriko Mikami-Saito, Satoshi Kikuchi, Akitoshi Kojima, Gaku Moriyama
Publikováno v:
J Thorac Dis
Background Immune-checkpoint inhibitors (ICIs) have been increasingly used for non-small cell lung cancer (NSCLC) treatment in recent years. Although insufficient, the rate of programmed death-ligand 1 expression has been adopted as a predictor of IC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc72d0c0dd8420064d87ee6c8f9f84e4
https://europepmc.org/articles/PMC8411181/
https://europepmc.org/articles/PMC8411181/
Autor:
Yoshiki Kuwabara, Yuriko Mikami-Saito, Maiko Toda, Satoshi Kikuchi, Kazutsugu Uematsu, Kosuke Sakai, Shintaro Mikami, Hiroaki Nishimura, Yusuke Hirata, Yumiko Kobayashi, Akihiko Gemma, Hiroyuki Kyoyama, Joji Kuramoto, Akitoshi Kojima, Gaku Moriyama
Publikováno v:
International journal of clinical oncology. 24(12)
In the eighth edition of the TNM classification of lung cancer, the M1b and M1c descriptors are newly defined by the number of extrathoracic metastases. To verify the prognostic value of these descriptors in Japan, we reclassified our cases and re-ev